Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,509.54
(
0.88%
)
US TECH 100
28,844.83
(
0.90%
)
Dow Jones
50,054.77
(
0.73%
)
Brent Oil
102.56
(
-1.09%
)
Bitcoin
81,364.79
(
2.62%
)
News Focus
News Focus
Post# of 438
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122977
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: Ecomike post# 51

Saturday, 10/30/2010 6:16:06 PM

Saturday, October 30, 2010 6:16:06 PM

Post# of 438

I see what looks like great news today on a brain cancer drug FDA approval for NVS!

The new Afinitor approval is for benign brain tumors, not brain cancer. It’s a very small indication that won’t move the needle for a company as large as NVS. Regards, Dew

p.s. One thing that will move the needle for NVS is generic Lovenox, which had $292M in 3Q10 sales following the launch on July 23 (#msg-55774996).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NVS News
More NVS News